Home The Word Brain My Amedeo FAQ Privacy About   


Amedeo C49

English + 你好 (nǐ hǎo) = limitless possibilities.
Start learning Mandarin Chinese today—for free, forever.

Amedeo C49 is completely free, for life. Next week: +49.


  Tuberculosis

  Free Subscription


19.05.2025

2 Clin Infect Dis
1 Eur J Clin Microbiol Infect Dis
1 J Clin Microbiol
3 PLoS One
1 Proc Natl Acad Sci U S A
1 Respir Med
1 Trop Med Int Health


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Clin Infect Dis

  1. REGAN JJ, Wang Z, Phares CR
    The Effect of Live-Virus Vaccines on Tests for Tuberculosis Infection During the US Immigration Medical Examination: Are Vaccines Causing False-Negative Results?
    Clin Infect Dis. 2025 May 15:ciaf129. doi: 10.1093.
    PubMed         Abstract available

  2. STADLER JAM, Kuhlin JJ, Molloy SF, Mtwa NN, et al
    Treatment Outcomes With an Oral Short Course Regimen for Rifampicin-resistant Tuberculosis in a High HIV Prevalence, Programmatic Setting in South Africa.
    Clin Infect Dis. 2025 May 9:ciaf112. doi: 10.1093.
    PubMed         Abstract available


    Eur J Clin Microbiol Infect Dis

  3. FEI ZT, Zhou DP, Huang W, Liu P, et al
    Clinical characteristics and outcomes of tuberculosis and non-tuberculous mycobacteria infections: a population-based study of concurrent and sequential infections.
    Eur J Clin Microbiol Infect Dis. 2025 May 9. doi: 10.1007/s10096-025-05151.
    PubMed         Abstract available


    J Clin Microbiol

  4. SERGE DIAGBOUGA P, Djibougou AD, Pease C, Alcaide A, et al
    Preliminary performance of the VIDAS TB-IGRA as an aid in the diagnosis of individuals infected with Mycobacterium tuberculosis.
    J Clin Microbiol. 2025 May 14:e0164124. doi: 10.1128/jcm.01641.
    PubMed         Abstract available


    PLoS One

  5. SHIN E, Yun JS, Lee YR, Cha HR, et al
    Efficacy and immunogenicity of rKVAC85B in a BCG prime-boost regimen against H37Rv and HN878 Mycobacterium tuberculosis strains.
    PLoS One. 2025;20:e0322147.
    PubMed         Abstract available

  6. BEYENE RA, Janse van Rensburg E
    Prevention and control of multidrug-resistance tuberculosis in Ethiopia: Patients' perspectives from the Oromia region.
    PLoS One. 2025;20:e0322054.
    PubMed         Abstract available

  7. NTSHIQA T, Velen K, Ginindza S, Nhlangulela L, et al
    Resistance to tuberculin skin test/interferon-gamma release assay conversion among highly TB exposed, HIV infected goldminers in South Africa.
    PLoS One. 2025;20:e0318819.
    PubMed         Abstract available


    Proc Natl Acad Sci U S A

  8. SANTAMARIA C, Biegas KJ, Lim PN, Cabral J, et al
    Trehalose dimycolate inhibits phagosome maturation and promotes intracellular M. tuberculosis growth via noncanonical SNARE interactions.
    Proc Natl Acad Sci U S A. 2025;122:e2423292122.
    PubMed         Abstract available


    Respir Med

  9. GAO W, Yang C, Wang T, Guo Y, et al
    Clinical predictive model for identifying high-risk factors in pleurisy tuberculoma patients.
    Respir Med. 2025;242:108039.
    PubMed         Abstract available


    Trop Med Int Health

  10. HAN N, Yan L, Yuan M, Chen Z, et al
    Characteristics and risk factors of drug-resistant tuberculosis in Sichuan, China: An observational study.
    Trop Med Int Health. 2025 May 15. doi: 10.1111/tmi.14126.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Tuberculosis is free of charge.